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Abstract Inducible nitric oxide synthase (iNOS) expres-
sion is altered in gastrointestinal diseases. Helicobacter
pylori (Hp) infection may have a critical role in iNOS
disregulation. We undertook this study to investigate pos-
sible chromatin changes occurring early during iNOS gene
activation as a direct consequence of Hp–gastric cells
interaction. We show that Hp infection is followed by
different expression and chromatin modifications in gastric
cells including (1) activation of iNOS gene expression, (2)
chromatin changes at iNOS promoter including decreased
H3K9 methylation and increased H3 acetylation and H3K4
methylation levels, (3) selective release of methyl-CpG-
binding protein 2 from the iNOS promoter. Moreover, we
show that Hp-induced activation of iNOS is delayed, but
not eliminated, by the treatment with LSD1 inhibitors. Our
data suggest a role for specific chromatin-based mecha-
nisms in the control of human iNOS gene expression upon
Hp exposure.
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Introduction
Helicobacter pylori (Hp) is a Gram-negative bacterium
involved in several gastric diseases. Persistent infection
with Hp may cause in humans chronic atrophic gastritis,
with development of intestinal metaplasia, dysplasia and
gastric carcinoma [1–6] as also demonstrated in animal
models [6–8]. Therefore, Hp is classified as a carcinogenic
agent class I. The mechanism of Hp pathogenicity is not
well understood, although both bacterial virulence and host
susceptibility factors have been associated with the devel-
opment of chronic gastric inflammation and gastric carci-
nogenesis [6–11].
Hp, through TLRs receptors, induces expression of host
inflammatory genes such as TNF-alfa, which in turn acti-
vates NF-kB, a transcription factor whose target genes
include iNOS [12–15]. Recent advances in basic research
on Hp-associated carcinogenesis have gradually clarified
that nitric oxide (NO)-derived iNOS plays a crucial role in
the process of gastric carcinogenesis [16, 17]. It has been
reported that iNOS is expressed in gastric mucosa from
patients with Hp-induced gastritis and that this expression
is closely related to inflammatory cell infiltration in the
gastric mucosa [18]. A great deal of evidence supports a
role of iNOS in promoting tumour development. A number
of activities may contribute to the tumour-enhancing
effects of NO, including DNA damage [19], increased
angiogenesis and blood flow [20], prevention of apopto-
tic cell death [21], activation of iNOS [22] and suppression
of the immune system [23]. Therefore, chemoprevention
by antioxidants or treatment against Hp was proposed
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and showed reducing the incidence of gastric cancer
[16, 24].
It has been suggested that epigenetic controls on iNOS
transcription may be operative. Specific studies on iNOS
have shown that lower DNA methylation in the gene pro-
moter is associated with increased expression and that the
human iNOS promoter was basally enriched with methyl-
ation of H3 lysine 9 in endothelial cells [25]. Although
much is known about the cis- and trans-regulatory factors
controlling activation of iNOS transcription by cytokines
and bacterial lipopolysaccharide (LPS), relatively little is
known about how local changes in chromatin structure
might participate in this process. A critical and still unan-
swered question is whether epigenetic changes observed in
gastric diseases may be a direct consequence of Hp
infection. To date, a few studies have addressed the pos-
sibility that Hp-induced host target genes activation may be
controlled by epigenetic mechanisms. One recent study
indicated that a change in H3S10 phosphorylation status at
IL-6 gene promoter is related to Hp infection through NF-
kB/ERK/p38 pathway [26]. We have recently demon-
strated that chromatin and DNA methylation modifications
accompany Hp-induced Cox-2 activation in gastric epi-
thelial cells [27] and LPS-induced IL-8 activation in human
intestinal epithelial cells [28]. In this work, we hypothe-
sized that Hp infection may have a direct impact on
epigenetic status of iNOS gene in gastric cells and that the
Hp-induced iNOS activation may be mediated by histone
modifications at iNOS gene regulatory regions. Our data
suggest a role for specific chromatin-based mechanisms in
the control of human iNOS gene expression upon Hp
exposure.
Materials and methods
Human gastric epithelial cell culture
MKN 28 cell line was derived from a human gastric tubular
adenocarcinoma and shows moderate gastric-type differ-
entiation; this cell line has proven to be a suitable in vitro
model for the study of interactions between Hp and the
gastric epithelium [29, 30]. MKN 28 cells were grown as
monolayers in DMEM Ham’s nutrient mixture F-12 (1:1;
Sigma, St. Louis, MO) supplemented with 10% FCS (Life
Technologies, Inc.) at 37C in a humidified atmosphere of
5% CO2. Tranylcypromine (TCP) and pargyline were from
Sigma.
Bacterial strains and coculture conditions
Hp strains used in this study were Hp wild-type strains
60190 (ATCC 49503, VacA?/cag PAI?) and CCUG
17874 (National Collection of Type Cultures, London,
England, 11637, VacA?/cagPAI?) containing the cag
pathogenicity island and secreting an active form of VacA
[31]. In contrast, the Hp mutant strain Tx30a (ATCC
51932, VacA-/cag PAI-) [32] lacks the cag pathogenicity
island and is unable to translocate CagA product into the
host gastric epithelial cells and produces a VacA protein
that fails to induce vacuolation in vitro [33, 34]. In addi-
tion, we also used E. coli strain DH5a (Stratagene). Bac-
teria were grown in brucella broth (DIFCO Laboratories,
Detroit, MI) supplemented with 1% Vitox (Oxoid,
Basingstoke, UK) and 5% FCS (Life Technologies, Inc.,
Paisley, UK) for 24–36 h at 37C in a thermostatic shaker
under microaerobic conditions. Bacteria were harvested by
centrifugation and added to gastric cells at concentration of
5 9 107 CFU/ml in DMEM supplemented with 10% FCS
at a multiplicity of infection (MOI) of 100. Cells were
incubated in the absence (controls) or in the presence of
bacteria for the indicated times. As controls, we also used
the CCUG 1784 (VacA?/cag PAI?) Hp strain, the
VacA-/cag PAI- Hp strain Tx30a and the E.coli strain
DH5alpha (Stratagene). The cells were suspended in
phosphate-buffered saline (PBS), and the density was
estimated by spectrophotometry (A405) and by micro-
scopic observation. To avoid the influence of serum, gastric
cells were starved for 16 h before and throughout the
period of treatment in all experiments.
Preparation of cell extracts and Western blot analysis
After incubation with Hp, cells were rapidly washed twice
with PBS to remove bacteria, then lysed in RIPA buffer
(PBS containing 1% Nonidet P 40, 0.5% sodium deoxy-
cholate, 0.1% SDS, 100 ng/ml phenylmethyl sulfonyl
fluoride and 10 lg/ml aprotinin). The samples, containing
50 lg protein per lane, were resolved by electrophoresis
using 12% SDS-PAGE precast gels (Bio-Rad Laboratories,
Milan, Italy) as appropriate and transferred to BA 85 0.45 m
PROTAN nitrocellulose filters (Schleicher & Schnell, Inc.,
Dassel, Germany). The blots were pretreated in Tris-buf-
fered saline containing 5% non-fat dry milk and 0.1%
Tween 20 and then incubated with anti-iNOS antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). Filters
were washed three times and then incubated with a horse-
radish peroxidase-conjugated secondary antibody against
goat or rabbit IgG (Amersham Pharmacia Biotech, Buck-
inghamshire, UK), developed using a commercial enhanced
chemiluminescence system (ECL, Amersham Pharmacia
Biotech, Buckinghamshire, UK). Immunoblot analysis
using anti-gamma-tubulin antisera was performed as a
control for protein loading. Western blot analyses of each
sample were performed at least three times. Protein levels
were quantified using the software Quantity One (Bio-Rad).
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RNA analysis by quantitative real-time PCR
Total RNA was isolated from MKN28 cells using an
RNeasy Mini kit (Qiagen) according to the manufacturer’s
instructions. Quantitative real-time PCR (qRT-PCR) was
carried out with cDNA using the QuantiTect SYBR Green
(Qiagen), gene-specific primers and an Chromo4 Real-
Time thermocycler (Biorad). Gene-specific primer pairs
were designed using Roche Applied Science software
(http://www.roche-applied-science.com/sis/rtpcr/upl/adc.jsp).
Primers were: Glucose-6-Phosphate Dehydrogenase, 50-GA
TCTACCGCATCGACCACT-30 (G6PDF) and 50-AGAT-
CCTGTTGGCAAATCTCA-30 (G6PDR); iNOS, 50- TCAC
GCATCAGTTTTTCAAGA-30 (iNOSF) and 50-TCACCG
TAAATATGATTTAAGTCCAC -30 (iNOSR). The reac-
tion mixture contained 2 ll cDNA, 0.3 lM of primers, and
10 ll of SYBR Green Mastermix (Qiagen), in a total vol-
ume of 20 ll. PCR cycles were as follows: 95C for
15 min followed by 40 cycles of 95C for 15 s, 58C for
30 s, and 72C for 30 s. Each reaction was performed in
triplicates. Melting curve analysis was performed to verify
specificity of products. The comparative method of relative
quantification (2-Ct) method [35] was used to calculate
expression levels of each target gene, normalized to the
housekeeping gene G6PD. Data are presented as fold
changes in gene expression. At least three independent
experiments were performed.
Chromatin immunoprecipitation (ChIP) assays
Cross-linking was performed by adding 1% formaldehyde
directly into tissue culture dishes containing 3 9 106
MKN28 at different time points after Hp infection, fol-
lowed by incubation at room temperature for 10 min. Cells
were washed twice with PBS, collected and pelleted by
centrifugation at 4009g for 5 min. The pellets were
resuspended in sonication buffer (containing 50 mM Tris–
HCl, pH 8.1, 10 mM EDTA, 1% SDS and protease
inhibitors) and incubated on ice for 10 min to lyse the
nuclei. Nuclear extracts were then sonicated to obtain
400–800 bp fragments of chromatin using a 3-mm (small
size) tip equipped Bandelin Sonoplus UW-2070 sonicator.
Immunoprecipitation was carried out according to the
protocol provided by Upstate Biotechnology (Lake Placid,
NY, USA). Briefly, chromatin was diluted tenfold in ChIP
dilution buffer. A small amount of chromatin was kept
aside at this step to be used as input control in subsequent
PCR reactions. Antibodies against acetyl-histone H3, his-
tone H3 (dimethyl-K4) and Histone H3 (dimethyl-K9)
(Abcam) were incubated with diluted chromatin at 4C
overnight. Immunoprecipitations were also carried out
without Ab (no Ab controls). Protein A Sepharose
(Amersham Biosciences), blocked with sheared salmon
sperm DNA, was used to collect Ab–chromatin complexes.
Immune complexes were then washed once with low-salt
immune complex wash buffer (containing 0.1% SDS, 1%
Triton X-100, 2 mM EDTA, 20 mM Tris–HCl, pH 8.1,
150 mM NaCl), once with high-salt immune complex wash
buffer (containing 0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris–HCl, pH 8.1, 500 mM NaCl), once
with LiCl immune complex wash buffer (0.25 M LiCl, 1%
IGEPAL-CA630, 1% deoxycholic acid, 1 mM EDTA,
10 mM Tris–HCl, pH 8.1) and twice with sterile TE buffer.
The chromatin (histone–DNA complexes) was eluted with
freshly prepared elution buffer (containing 1% SDS and
0.1 M NaHCO3), followed by reverse cross-linking with
0.3 M NaCl at 65C for 4–5 h. DNA fragments were then
purified with QIAquick spin column followed by qRT-PCR
or semiquantitative PCR. Immunoprecipitated DNA
recovered from ChIP assays were quantitated by qRT-PCR
using a 7500 Chromo4 Real-Time thermocycler (Biorad).
The primers for the iNOS promoter, used for qRT-PCR
were: PNOSF 50-AAGGGGAGAGGAGGGAAAAATT
TGTG-30 and PNOSR, 50-GAGGCGCTGCTGAGGAG
TTCCTG- 30. The reaction mixture contained 2 ll of ChIP
or input DNA, 0.3 lM of primers and 10 ll of SYBR
Green Mastermix (Qiagen) in a total volume of 20 ll. PCR
cycles were as follows: 95C for 15 min followed by 40
cycles of 95C for 15 s, 62C for 30 s and 72C for 30 s.
Input DNA was the unbound fraction of the non-immu-
noprecipitated sample. Melting curve analysis revealed a
single PCR product. Serial dilutions of input DNA revealed
that PCR results were linear from 100 to 0.1 ng and were
used to calculate absolute amounts of PCR products. No
antibody controls were performed showing comparable
results among the different reactions (data not shown).
Results are presented as input percentage, and calculations
take into account the values of at least three independent
experiments.
LSD1 activity assay
Assays were performed using the colorimetric LSD1
activity assay kit (Abcam) according to the manufacturer’s
instructions. Briefly, 50 lg of nuclear extracts from
MKN28 cells, pretreated with 3 mM of pargyline or 2 mM
TCP or with DMSO and infected with Hp at different
times, was diluted in 49 ll of LSD1 assay buffer, followed
by addition of 1 ll of the LSD1 substrate (H3K4me2), and
samples were incubated at 37C for 90 min; then, 50 ll of
capture and detection antibody solution was added and
incubated at room temperature for 60 and 30 min,
respectively. Subsequently, the reactions were stopped by
adding 100 ll of developer solution and left for additional
10 min at room temperature away from light. Samples
were then stopped and read in an ELISA plate reader at
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450 nm. LSD1 activity was expressed as relative OD val-
ues per mg of protein sample. The kit provides control
inhibitor and positive control assays that consist of purified
LSD1 enzyme treated or not with TCP (2 mM),
respectively.
Results
Induction of iNOS expression by Hp in MKN28 gastric
cells
Hp infection of gastric mucosa leads to activation of iNOS
gene [18]. In order to investigate early transcriptional
events occurring at the human iNOS promoter gene upon
induction by Hp, we utilized a human gastric epithelial cell
line, MKN28, as a model. MKN28 cells were grown to
confluence and incubated with bacterial suspension of Hp
60190 (wild-type) strain, the mutant Hp Tx30a or Esche-
richia coli (DH5alpha), and then iNOS mRNA levels were
measured. A time-dependent increase of iNOS mRNA in
response to Hp infection was observed (Fig. 1a). iNOS
mRNA expression showed a pronounced peak at 4 h post-
infection and declined after 48 h. Same experiments using
a different strain of Hp (strain CCUG 17874) gave com-
parable results (data not shown) indicating that the
observed pattern of iNOS induction was not related to a
specific strain. Moreover, when MKN28 cells were incu-
bated with a VacA-/cagPAI- Hp strain (Tx30a), a com-
parable increase in iNOS expression was observed
(Fig. 1a) showing that iNOS activation pattern was not
dependent on VacA/CagPAI status. Finally, to determine
whether similar effects were induced by different Gram-
negative bacteria, we studied the effects of E. coli. The
infection of cells with E. coli DH5alfa strain did not have
any effect on iNOS expression (Fig. 1a) suggesting that the
observed effects were specific for Hp. Western blot anal-
yses showed that levels of iNOS protein increased fol-
lowing a pattern consistent with that predicted by the
mRNA levels (Fig. 1b, c).
Hp-induced iNOS activation is accompanied
by both histone H3 acetylation and methylation
modifications
In order to investigate whether specific changes in histone
modifications occurred at iNOS promoter during Hp-
induced gene activation, we performed ChIP experiments.
First, we determined whether iNOS activation corre-
sponded to increased levels of histones H3 acetylation at
iNOS promoter region. Cells were incubated with Hp for
different times, and chromatin was immunoprecipitated
with anti-acetyl-H3 antibodies; then, PCR amplifications
were performed using promoter-specific primers (see
Fig. 2a and ‘‘Materials and methods’’). We found that the
H3 acetylation state was transiently modulated upon
infection. The histone H3, initially lowly acetylated, was
highly acetylated after 4 h while the deacetylated state was
restored after 48 h (Fig. 2a). Hyper-acetylation of histone
H3 is in agreement with expression pattern of the iNOS
Fig. 1 Hp induces expression of the iNOS gene. MKN28 cells were
grown to confluence and incubated with DMEM (control) or with Hp
60190, Hp Tx30a and E. coli (DH5alpha). a Total RNA was isolated
at indicated time points after infection and used in qRT-PCR
reactions. The iNOS levels were evaluated relative to time point 0
(control) and normalized to GAPDH levels. Data points represent the
average of three independent experiments with the standard deviation
from the mean shown. Similar results were obtained in 3 independent
experiments. b Lysates were collected at the indicated time points
after infection in RIPA buffer and 50 g of protein samples were
loaded for electrophoresis. The expression levels of iNOS were
detected using anti-iNOS antibody. The levels of tubulin were used to
demonstrate equal loading. A representative blot is shown. c Protein
levels were quantified using the software Quantity One (Bio-Rad).
The iNOS protein levels were normalized to tubulin levels and
expressed as relative to untreated control cells (C = control). Data
points represent the average of three independent experiments with
the standard deviation from the mean shown
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gene. Thus, H3 acetylation levels are predictive of Hp-
mediated iNOS gene inducibility. Then, we determined
whether the induction of iNOS gene upon Hp infection was
accompanied by modification of histone methylation state
at iNOS promoter. Antibodies against dimethylated H3K4
(H3K4me2) and dimethylated H3K9 (H3K9me2) were
used in ChIP assays. We found that the levels of H3K4me2
were low in non-infected gastric cells and significantly
increased at 4 h after Hp infection, returning to a near basal
level by 48 h (Fig. 2c). In contrast, H3K9me2 decreased
significantly in gastric epithelial cells by 1 h after Hp
infection, with a robust decrease at 4 h, and then gradually
returned to its basal state at 48 h (Fig. 2d). These results
are in agreement with the repressive role of H3K9me2,
with the activating role described for H3K4me2 in gene
transcription [36–39] and with expression pattern of the
iNOS gene.
Effect of Hp on the recruitment of MeCP2 at iNOS
promoter
MeCP2 is known to play an important role in gene
expression by recruiting H3 lysine 9 methyltransferases to
promoters, thereby mediating nucleosomal H3 lysine 9
methylation [40, 41]. Since the expression of iNOS induced
by Hp, in MKN28 cells, correlates with decreased meth-
ylation levels of histone H3K9me2, we hypothesized that
Hp infection might mediate this effect by reducing the
recruitment of MeCP2 to the iNOS promoter. To test this
hypothesis, we performed ChIP assays. As shown in Fig. 3,
MeCP2 was readily detected at iNOS promoter. At 4-h
time point post-infection, we observed a release of MeCP2
from the iNOS promoter, and its levels were restored after
48 h (Fig. 3). These results indicated that the decreased
methylation levels of H3K9me2 and the induction of iNOS
Fig. 2 Hp-mediated iNOS gene activation is accompanied by both
histone H3 acetylation and methylation changes. a Schematic repre-
sentation of the iNOS promoter showing the locations of PCR primers
used for ChIP assay. Chromatin from MKN28 cells was harvested at
the indicated time points after infection with Hp. Results of ChIP
analyses using anti-acetyl H3 (b), anti-dimethyl H3K4 (c) or anti-
dimethyl H3K9 (d) antibodies are shown. Recovered DNA sequences
were quantified by qRT-PCR. Data points represent the average of
three independent experiments with the standard deviation from the
mean shown
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transcription by Hp are accompanied by the release of
MeCP2 from iNOS promoter.
LSD1 inhibitors reduce Hp-induced H3 acetylation
and H3K4 methylation at the iNOS promoter and delay
iNOS activation
LSD1 has both repressive (H3K4 demethylation) and
activating (H3K9 demethylation) activities [42, 43]. LSD1
demethylates lysine residues via flavin–adenine dinucleo-
tide-dependent reaction, and this reaction can be inhibited
by monoamineoxidase inhibitors (MAOIs) [44–47].
Moreover, LSD1 is highly expressed in gastric adenocar-
cinoma [48]. For these reasons, we investigated the effect
of MAOIs on Hp-induced H3 acetylation and H3K4 and
H3K9 methylation at the iNOS promoter by chromatin
immunoprecipitation (ChIP) experiments (Fig. 4). MKN28
cells were pretreated with 3 mM of pargyline or 2 mM
TCP or with DMSO before infection with Hp at different
time points. Enzymatic assays using nuclear extract of
treated and untreated cells were performed as a control.
These assays showed that LSD1 enzymatic activity was
repressed by both pargyline and TCP (Supplemental Fig-
ure S1). ChIP analyses showed that the treatments of
MKN28 cells with either pargyline or TCP led to a time-
dependent decrease in levels of H3 acetylation and
H3K4me2 at iNOS promoter (Fig. 4a, b). Conversely, no
modifications of H3K9me2 levels were observed (Fig. 4c).
Then, we investigated the impact of pargyline and TCP on
Hp-induced iNOS activation (Fig. 5). While no significant
differences in basal iNOS levels between pretreated and
untreated cells were observed (time point 0), we found
that iNOS activation peak was delayed from 1-h time
point, observed in untreated cells, to 6-h time point when
the cells were treated with either pargyline or TCP
(Fig. 5).
Discussion
The present study demonstrates for the first time that Hp-
dependent iNOS activation is associated with specific
chromatin modifications at the iNOS promoter. We show
that (1) Hp-induced iNOS activation is accompanied by
decreased H3K9me2 and increased H3 acetylation and
H3K4me2 levels, (2) MeCP2 is released from iNOS pro-
moter upon Hp infection, and (3) the activation of iNOS
gene after Hp infection is delayed, but not eliminated, by
the treatment with LSD1 inhibitors.
Fig. 3 Time course of Hp-induced binding of MeCp2 at the iNOS
promoter. MKN28 cells were grown to confluence and exposed to Hp
for the indicated time points. Chromatin was harvested and precip-
itated with anti-MeCp2 antibody. Recovered DNA sequences were
quantified by qRT-PCR. Data points represent the average of three
independent experiments with the standard deviation from the mean
shown
Fig. 4 Effect of pargyline and tranylcypromine on Hp-induced
histone H3 acetylation and methylation at iNOS promoter region.
MKN28 cells were grown to confluence and treated with DMSO or
3 mM pargyline (P) or 2 mM TCP (TCP) after incubation with
DMEM (control) or with Hp 60190 for indicated time points. Results
of ChIP analyses using anti-acetyl H3 (a), anti-dimethyl H3K4 (b) or
anti-dimethyl H3K9 (c) antibodies are shown. Recovered DNA
sequences were quantified by qRT-PCR using primers described in
Fig. 4a. Data points represent the average of three independent
experiments with the standard deviation from the mean shown
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A novel strategy used by bacterial pathogens to interfere
with key cellular processes may include direct effects on
host epigenetics. Few recent studies demonstrate that
bacteria are indeed able to provoke histone modifications
and chromatin remodelling in infected cells [49]. The
effects of LPS, Mycobacteria, Shigella, Listeria and Heli-
cobacter on some aspects of host epigenetics have been
recently reported [49]. It has been shown that the expres-
sion of IL-6 is modulated by Hp through activation of
ERK/p38/MSK1 cascade and consequent H3S10 phos-
phorylation, which in turn is necessary for IL-6 activation
[26]. We have recently demonstrated that chromatin and
DNA methylation modifications accompany Hp-induced
Cox-2 activation in gastric epithelial cells [27]. Another
important aspect linking epigenetic modification to Hp
infection are the well established alterations of chromatin
and DNA methylation profiles described at several loci in
gastrointestinal cancers [50–52]. However, conflicting data
are reported about the direct involvement of pre-existing
Hp infection of gastric mucosa as a determining factor for
epigenetic alterations observed in gastric diseases. We
should consider that many events, including inflammation,
cancer progression and stochastic epigenetic changes, may
occur between Hp infection and clinical diagnosis, and thus
it is expected that a wide spectrum of epigenetic alterations
may be observed in pathologic samples regardless of those
directly provoked by the Hp infection.
In this work, we have investigated the epigenetic
changes occurring at iNOS locus during the first 48 h after
exposure of gastric cells to Hp and, thus, directly attrib-
utable to host–parasite interaction. We show that MKN28
cells express iNOS mRNA and proteins weakly under the
unstimulated condition, and the expression levels increase
dramatically upon Hp stimulation concomitantly with the
occurrence of several chromatin changes. A role of histone
acetylation in the regulation iNOS gene was previously
suggested in studies performed in macrophages cells under
different kind of stimulation [53]. In this work, we have
shown that transient changes of the histone H3 acetylation
state accompany the first phases of Hp infection of gastric
cells. Modulation of histone deacetylase expression in Hp-
exposed gastric cells has been recently described in an
animal model [54]. Moreover, our results indicate that the
main drivers of iNOS activation upon Hp exposure are the
increase in H3K4me2 levels and the decrease in H3K9
methylation state. Accordingly, previous reports indicate
that the increase in H3K4me2, as well as the decrease in
H3K9me2 levels, marks transcriptionally active chromatin
structure [36–39].
Because LSD1 has both repressive and activating
effects through H3K4 and H3K9 demethylation capability
[42, 43], we investigated Hp-dependent histone modifica-
tion occurring in MKN28 cells pretreated with LSD1
inhibitors. We show that both pargyline and TCP have no
effects on iNOS basal levels while both inhibitors have a
strong influence on Hp-induced iNOS activation. In fact,
Fig. 5 LSD1 inhibitors treatment reduced Hp-induced iNOS gene
expression. MKN28 cells were grown to confluence and treated with
DMSO or 3 mM pargyline (P) or 2 mM TCP (TCP) after incubation
with DMEM (control) or with Hp 60190 for indicated time points.
a Protein levels were quantified using the software Quantity One
(Bio-Rad). The iNOS protein levels were normalized to tubulin levels
and expressed as relative to untreated control cells (C = control).
iNOS protein levels before Hp induction and 24 h after pretreatment
with DMSO, pargyline or TCP are shown (time point 0). b Total RNA
was isolated at indicated time points after infection and used in qRT-
PCR reactions. The iNOS levels were evaluated relative to control
untreated cells and normalized to GAPDH levels. Data points
represent the average of three independent experiments with the
standard deviation from the mean shown
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both LSD1 inhibitors repress Hp-dependent iNOS activa-
tion during the first 4 h after Hp infection; however, they
cannot prevent the iNOS induction at later times (6 h). This
phenomenon could be explained by the fact that early
Hp-dependent iNOS activation requires LSD1 (or other
monoamineoxidase) activity while the later iNOS peak
(6 h) may be the result of different putative enzymatic
activity. Our data suggest a model in which LSD1, limited
to the first phases of infection, and MeCP2 may play an
intermediary role between repressive and active histone
marks by removing methylation and providing the naked
lysine residue to be acetylated (Fig. 6).
Further studies will possibly elucidate the wide variety
of epigenetic profiles observed at iNOS gene in gastritis
and gastric tumours that may be a result of different
mechanisms including those derived by direct host–para-
site interaction and additional events occurring during
inflammation and cancer progression.
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